Biosensor Recession proof -heartstent biz

nomura target is more realistic, it really knows well for this company,1.9 is achieveable

oi mardiindo, why do you think Nomura knows this company well?
[hr]
[mardiindo sekuritas 17-07-2012]:

nomura target is more realistic, it really knows well for this company,1.9 is achieveable

Initiate at Buy with PO of S$1.55 (29% upside potential) by Bank of America

For full report, please email to tplim1975@gmail.com

Closed at $1.225 today, not sure whether to go in or not.

No dividend.....Clinical trials do take a long time to validate a product.

Good thing is this company is an innovative one, and doing something good for society in terms of the drug-eluting stents, etc.

ok, eluded me already at $1.25

Biosensor recession proof -heartstent biz without the incentive of dividend it may not be so attractive for investors to hold long term especially during this uncertain times.
Cordlife another recession proof medical stock looks atttractive for investors to hold long term with good dividend pay out. Cordlife is ready to power after recent bear purge out.